v3 Template
B
Brise Pharmaceuticals Co., LTD.
Biopharmaceutical
Founded
--
Employees
--
Total Funding
$20.0M
Funding Rounds
1
Last Funding
2024-04-22
About Brise Pharmaceuticals Co., LTD.
Brise Pharmaceuticals is a clinical stage biopharmaceutical company established in June 2021 in Shanghai, China. The company focuses on developing innovative and highly differentiated treatment solutions for severe pain conditions, such as migraine, inflammatory pain, and neuropathic pain. Their mission is to provide safe, effective, and accessible pain treatment solutions to patients in China and worldwide through relentless innovation.
Products & Services
Development Pipeline:Brise Pharma is building a balanced pipeline based on clinically validated targets, utilizing optimal modalities and technologies, as well as original innovations for pain treatment solutions.
Specialties
Pain Management
Severe Pain Conditions
Migraine Treatment
Inflammatory Pain Treatment
Neuropathic Pain Treatment
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series Pre-A and Pre-A+ T: - FT: Series Pre-A and Pre-A+ |
A: 20000000 MR: - FA: approximately $20 million FAN: 20000000 |
D: 2024-04-22 FD: 2024-04-22 |
6 investors |
Series Pre-A and Pre-A+
Latest
2024-04-22
$20.0M
6 investors (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Brise Pharmaceuticals Co., LTD. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- brisepharma.com
- Industries
- Biopharmaceutical
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro